Tech Company Financing Transactions
RenaMed Biologics Funding Round
On 9/7/2006, RenaMed Biologics raised $40 million in funding from TVM Capital, Edbi and MDS Capital.
Transaction Overview
Company Name
Announced On
9/7/2006
Transaction Type
Venture Equity
Amount
$40,000,000
Round
Undisclosed
Investors
Proceeds Purpose
The funds will be used to continue the clinical development of the company's Renal Bio-Replacement Therapy for Acute Renal Failure, as well as support its move to a new headquarters and manufacturing facility in Westborough, MA.
Company Information
Company Status
Out of Business
Industry
Biopharmaceutical
Mailing Address
6 Court Drive
Lincoln, RI 02865
USA
Lincoln, RI 02865
USA
Phone
Website
Email Address
Overview
RenaMed Biologics, Inc. is the leading clinical stage company focused on the development of proprietary Bio-Replacement Therapies for critical disease states involving compromised kidney function.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Gregory Phelps
Chief Financial Officer
Mark Fitzpatrick
Chief Medical Officer
Bradley Maroni
Chief Scientific Officer
David Humes
Browse more venture capital transactions:
Prev: 9/6/2006: Infinite Power Solutions venture capital transaction
Next: 9/7/2006: Handmark venture capital transaction
Share this article
Where The Data Comes From
We do our best to report on all VC transactions involving tech companies. All VC database entries reported here are sourced from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs